BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38663162)

  • 21. Spanish post-menopausal women's viewpoints on hormone therapy.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
    Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of hormone replacement therapy in women with a history of cervical adenocarcinoma.
    Richardson A; Watson L; Persic M; Phillips A
    Post Reprod Health; 2021 Sep; 27(3):167-173. PubMed ID: 34255590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
    Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
    BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy.
    Tucker PE; Bulsara MK; Salfinger SG; Tan JJ; Green H; Cohen PA
    Maturitas; 2016 Mar; 85():42-8. PubMed ID: 26857878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement in premenopausal women treated with bilateral oophorectomy for ovarian cancer - a nationwide population-based study.
    von Kartaschew ÅE; Dahm-Kähler P; Rodriguez-Wallberg KA; Holmberg E; Rådestad AF
    Gynecol Oncol; 2022 Dec; 167(3):476-482. PubMed ID: 36216625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women's knowledge of and attitudes towards hormone replacement therapy.
    Lewin KJ; Sinclair HK; Bond CM
    Fam Pract; 2003 Apr; 20(2):112-9. PubMed ID: 12651782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian cancer and hormone replacement therapy in the Million Women Study.
    Beral V; ; Bull D; Green J; Reeves G
    Lancet; 2007 May; 369(9574):1703-10. PubMed ID: 17512855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of Hormone Replacement Therapy Knowledge and Current Hormone Replacement Therapy Use.
    Doamekpor LA; Head SK; South E; Louie C; Zakharkin S; Vasisht K; Bersoff-Matcha S
    J Womens Health (Larchmt); 2023 Mar; 32(3):283-292. PubMed ID: 36459626
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of menopausal status and use of hormone replacement therapy on radiation dose from mammography in routine breast screening.
    Whitaker CJ; Kelly CM; Faulkner K; Stamp EC
    Br J Radiol; 2006 Jul; 79(943):597-602. PubMed ID: 16823065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.
    Sullivan SD; Sarrel PM; Nelson LM
    Fertil Steril; 2016 Dec; 106(7):1588-1599. PubMed ID: 27912889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).
    Ishizuka B
    Front Endocrinol (Lausanne); 2021; 12():626924. PubMed ID: 33716979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why do women doctors in the UK take hormone replacement therapy?
    Isaacs AJ; Britton AR; McPherson K
    J Epidemiol Community Health; 1997 Aug; 51(4):373-7. PubMed ID: 9328541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menopausal Hormone Therapy, an Ever-Present Topic: A Pilot Survey about Women's Experience and Medical Doctors' Approach.
    Aquino CI; Stampini V; Osella E; Troìa L; Rocca C; Guida M; Faggiano F; Remorgida V; Surico D
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792957
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of climacteric symptoms in survivors of gynaecological cancer.
    Biglia N; Bounous VE; Sgro LG; D'Alonzo M; Gallo M
    Maturitas; 2015 Nov; 82(3):296-8. PubMed ID: 26341044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant fall in hormone replacement therapy prescription in general practice.
    Lagro-Janssen A; Knufing MW; Schreurs L; van Weel C
    Fam Pract; 2010 Aug; 27(4):424-9. PubMed ID: 20406789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.